Biotech May Offer Compelling Value (4 min read)
The iShares Biotechnology ETF (IBB) is the largest US-listed biotech ETF. Despite being 13% lower this year, it is still outperforming the S&P 500 that has dropped about 17%. Given the strong fundamentals supporting health care and innovation that improve medical technology, the biotech sector and IBB may have a lot more room to run in 2023. More detailed analysis on this sector and IBB is available in the article.